Microbiome Testing During Cancer Recovery | Nurish'd

Microbiome Testing During Cancer Recovery: Supporting Your Gut After Treatment

Cancer treatment — chemotherapy, radiation, immunotherapy, antibiotics — has profound effects on the gut microbiome. Many of the GI side effects of cancer treatment (diarrhea, constipation, nausea, mucositis, appetite loss) are at least partially mediated by treatment-induced microbiome disruption. And after treatment, the state of your gut microbiome is increasingly recognized as relevant to recovery, nutritional status, and potentially long-term recurrence risk. Microbiome testing during cancer recovery provides data that helps a Nurish'd oncology dietitian build the most targeted nutritional support possible.

Order Your Test Kit

Join thousands getting expert dietitian support for:

$0*

*Dependent on your plan's coverage and co-pay structure.

How Cancer Treatment Affects the Gut Microbiome

Cancer treatments profoundly disrupt the gut microbiome in ways that contribute to both treatment side effects and recovery challenges:

Chemotherapy — Most chemotherapy agents cause direct damage to rapidly dividing cells, including gut epithelial cells and many gut bacteria. The result is typically reduced diversity, loss of beneficial species, and often overgrowth of potentially pathogenic bacteria. Some chemotherapy agents (particularly platinum-based drugs and taxanes) are associated with significant microbiome depletion.

Radiation (abdominal/pelvic) — Radiation to the GI region directly damages gut tissue and the associated microbiome, often causing radiation enteritis — inflammation with long-term effects on gut function and microbiome composition.

Broad-spectrum antibiotics — Frequently used in cancer treatment protocols, antibiotics cause some of the most dramatic acute microbiome disruption. Recovery of pre-antibiotic diversity can take months to years without active intervention.

Immunotherapy — Checkpoint inhibitors (PD-1, PD-L1 inhibitors) have complex and bidirectional relationships with the microbiome. Intriguingly, certain microbiome profiles are associated with better immunotherapy response — an active area of research.

Corticosteroids and immunosuppressants — Commonly used supportive medications that alter gut immune-microbiome interactions.

What Microbiome Testing Shows During Recovery

For cancer survivors, microbiome testing after treatment typically reveals:

Dramatically reduced diversity — Treatment-related diversity loss is often severe and persistent without active intervention. Rebuilding diversity is a primary goal of post-treatment nutritional support.

Depleted beneficial species — Bifidobacterium, Lactobacillus, Faecalibacterium prausnitzii, and Akkermansia are commonly depleted after treatment, contributing to ongoing GI symptoms and nutritional challenges.

Elevated potentially pathogenic species — The microbiome vacuum created by treatment depletion can be filled by opportunistic bacteria, contributing to ongoing GI dysfunction.

Reduced SCFA production capacity — Low butyrate-producing bacteria after treatment impairs gut lining regeneration — particularly relevant after chemotherapy-induced mucositis.

Immunotherapy response markers — Increasingly, specific microbiome profiles are associated with better or worse immunotherapy outcomes. While not yet standard of care, this is a rapidly developing area.

For cancer survivors, microbiome testing after treatment typically reveals:

Dramatically reduced diversity — Treatment-related diversity loss is often severe and persistent without active intervention. Rebuilding diversity is a primary goal of post-treatment nutritional support.

Depleted beneficial species — Bifidobacterium, Lactobacillus, Faecalibacterium prausnitzii, and Akkermansia are commonly depleted after treatment, contributing to ongoing GI symptoms and nutritional challenges.

Elevated potentially pathogenic species — The microbiome vacuum created by treatment depletion can be filled by opportunistic bacteria, contributing to ongoing GI dysfunction.

Reduced SCFA production capacity — Low butyrate-producing bacteria after treatment impairs gut lining regeneration — particularly relevant after chemotherapy-induced mucositis.

Immunotherapy response markers — Increasingly, specific microbiome profiles are associated with better or worse immunotherapy outcomes. While not yet standard of care, this is a rapidly developing area.

Microbiome-Guided Nutrition for Cancer Recovery

Post-cancer nutrition has two phases that can be guided by microbiome data:

Phase 1: Recovery and repletion (during and immediately after treatment)
Priority is maintaining nutritional status, managing side effects, and supporting gut healing. High protein (1.2–1.5g/kg), easy-to-tolerate foods, targeted probiotic support, and gut-barrier-supporting nutrients (zinc, glutamine, butyrate) are central.

Phase 2: Cancer-protective dietary pattern (after recovery)
Research supports a predominantly plant-based, high-fiber, low-processed dietary pattern for cancer survivorship and reduced recurrence risk. This pattern also happens to be optimal for microbiome diversity recovery.

Cancer-type specific considerations:

  • Colorectal cancer survivors: Microbiome-informed fiber reintroduction after surgery, with attention to anastomosis health

  • Breast cancer: Gut microbiome influences estrogen metabolism (the estrobolome) — relevant for hormone-receptor-positive breast cancer survivors on aromatase inhibitors

  • Prostate cancer: Similar estrobolome considerations; metabolic health post-ADT is microbiome-relevant

Nurish'd's oncology-specialized RDs integrate your microbiome data with your cancer type, treatment history, current medications, and nutritional status for a comprehensive post-cancer nutrition plan.

Get Started with Your Microbiome Test

Is the microbiome test covered by insurance?
Microbiome testing is typically not covered by traditional health insurance. However, Nurish'd microbiome tests are HSA and FSA eligible — meaning you can use your pre-tax health savings account or flexible spending account dollars to cover the cost and reduce your effective out-of-pocket expense.

Good news on the clinical side: the registered dietitian sessions that accompany your results through Nurish'd are billable to most major insurance plans for qualifying diagnoses (diabetes, CKD, heart disease, obesity, eating disorders, and more). Many patients pay little to nothing for their RD sessions while paying out-of-pocket or through HSA/FSA for the test itself.

Ready to get started? Here's how:

New to Nurish'd?
Create your free account and order your microbiome test — receive your kit, complete your sample at home, and have results uploaded directly to your account. Book an RD session to interpret your results and build your personalized nutrition plan. HSA/FSA cards accepted at checkout.

Already a Nurish'd member?
Purchase your microbiome test here — your results sync automatically to your account. HSA/FSA eligible.

Want to learn more before you commit?
Explore our microbiome testing page — what we test for, how the process works, and what your results include.

Nurish'd is the only platform where your microbiome test results connect directly to a registered dietitian's interpretation and a personalized meal plan. The test is the starting point — what you do with the results is what changes your health.

What Happens After Your Microbiome Test

Most microbiome tests hand you a PDF and leave you to figure it out. Nurish'd does something fundamentally different. After your sample is processed and your results are uploaded to your Nurish'd account, you connect with a registered dietitian who reviews your microbiome data in the context of your health history, current diet, symptoms, and goals. Your RD translates the science into a practical, personalized nutrition plan — specific foods, meal patterns, and dietary strategies targeted at your microbiome profile and your health condition. From there, Nurish'd's medically tailored meal delivery can bring that plan to life — meals designed around your microbiome results and your dietitian's recommendations, delivered fresh to your door. The test is the starting point. The nutrition plan is where the health outcomes happen.

Most microbiome tests hand you a PDF and leave you to figure it out. Nurish'd does something fundamentally different. After your sample is processed and your results are uploaded to your Nurish'd account, you connect with a registered dietitian who reviews your microbiome data in the context of your health history, current diet, symptoms, and goals. Your RD translates the science into a practical, personalized nutrition plan — specific foods, meal patterns, and dietary strategies targeted at your microbiome profile and your health condition. From there, Nurish'd's medically tailored meal delivery can bring that plan to life — meals designed around your microbiome results and your dietitian's recommendations, delivered fresh to your door. The test is the starting point. The nutrition plan is where the health outcomes happen.

Find Dietitian's in your area

Dietitian listeing to a client on a virtual appointment

45:38

Dietitian listeing to a client on a virtual appointment

45:38

Frequently Asked Questions

When should I get a microbiome test during cancer treatment?
After completing active treatment is typically the most useful time — capturing the post-treatment state that nutritional intervention can address. Testing during active treatment is possible but results change rapidly with ongoing treatment.

Can microbiome-targeted nutrition reduce cancer recurrence risk?
The connection between microbiome, diet, and cancer recurrence is an active research area. Plant-based, high-fiber dietary patterns are broadly associated with reduced recurrence risk for colorectal cancer and potentially others, with microbiome-mediated mechanisms proposed. This is a research-supported but not yet fully established area.

I'm on immunotherapy — is microbiome testing relevant?
Yes — and increasingly so. Research shows that specific microbiome profiles predict better immunotherapy response. While microbiome manipulation to improve immunotherapy response is not yet standard of care, being aware of your microbiome status during immunotherapy is increasingly clinically relevant.

Should my oncologist know I'm doing microbiome testing?
Yes — transparency with your oncology team is important. Nurish'd's RDs work collaboratively with your oncology care team, not independently of it.

When should I get a microbiome test during cancer treatment?
After completing active treatment is typically the most useful time — capturing the post-treatment state that nutritional intervention can address. Testing during active treatment is possible but results change rapidly with ongoing treatment.

Can microbiome-targeted nutrition reduce cancer recurrence risk?
The connection between microbiome, diet, and cancer recurrence is an active research area. Plant-based, high-fiber dietary patterns are broadly associated with reduced recurrence risk for colorectal cancer and potentially others, with microbiome-mediated mechanisms proposed. This is a research-supported but not yet fully established area.

I'm on immunotherapy — is microbiome testing relevant?
Yes — and increasingly so. Research shows that specific microbiome profiles predict better immunotherapy response. While microbiome manipulation to improve immunotherapy response is not yet standard of care, being aware of your microbiome status during immunotherapy is increasingly clinically relevant.

Should my oncologist know I'm doing microbiome testing?
Yes — transparency with your oncology team is important. Nurish'd's RDs work collaboratively with your oncology care team, not independently of it.